Chakrabarty, Trisha http://orcid.org/0000-0002-2262-8697
McInerney, Shane J.
Torres, Ivan J.
Frey, Benicio N.
Milev, Roumen V.
Müller, Daniel J.
Rotzinger, Susan
Kennedy, Sidney H.
Lam, Raymond W.
,
Clinical trials referenced in this document:
Documents that mention this clinical trial
Cognitive Outcomes with Sequential Escitalopram Monotherapy and Adjunctive Aripiprazole Treatment in Major Depressive Disorder: A Canadian Biomarker Integration Network in Depression (CAN-BIND-1) Report
https://doi.org/10.1007/s40263-021-00793-1
Funding for this research was provided by:
Ontario Brain Institute
Article History
Accepted: 11 January 2021
First Online: 8 March 2021
Declarations
:
: CAN-BIND is an Integrated Discovery Program carried out in partnership with, and financial support from, the Ontario Brain Institute [grant title “Canadian Biomarker Integration Network for Depression (CAN-BIND)”], an independent non-profit corporation, funded partially by the Ontario government. The opinions, results, and conclusions are those of the authors and no endorsement by the Ontario Brain Institute is intended or should be inferred. Additional funding was provided by CIHR, Lundbeck, Bristol-Myers Squibb, Pfizer and Servier. Funding and/or in kind support is also provided by the investigators’ universities and academic institutions. All study medications are independently purchased at wholesale market values.
: Trisha Chakrabarty has received grant funding from the Michael Smith Foundation for Health Research and the National Research Council Canada. Shane J. McInerney has received advisory panel income from Janssen and research grant funding through the Healthy Minds Canada/Pfizer Canada Workplace Depression Awards. Ivan J. Torres has received consulting fees or sat on advisory boards for Lundbeck Canada, Sumitomo Dainippon and Community Living British Columbia. Benicio N. Frey has received research grants from Pfizer. Roumen V. Milev has received honoraria for ad hoc speaking or advising/consulting or received research funds from Lundbeck, Kye, Shire, Sunovion, Janssen, Lallemand, Allergan, Otsuka, Canadian Institutes of Health Research, Canadian Biomarker Integration Network for Depression, Ontario Brain Institute and Ontario Mental Health Foundation. Daniel J. Müller has received research funds from the Centre for Addiction and Mental Health Foundation, Canadian Institutes of Health Research and the National Institute of Health. Susan Rotzinger holds a patent “Teneurin C-Terminal Associated Peptides (TCAP) and methods and uses thereof. Inventors: David Lovejoy, R.B. Chewpoy, Dalia Barsyte, Susan Rotzinger.” Sidney H. Kennedy has received research funding or honoraria from the following sources: Abbott, Alkermes, Allergan, Boehringer lngelheim, Brain Canada, Canadian Institutes for Health Research, Janssen, Lundbeck, Lundbeck Institute, Ontario Brain Institute, Ontario Research Fund, Otsuka, Pfizer, Sanofi, Servier, Sunovion and Xian-Janssen. Sidney H. Kennedy holds stock in Field Trip Health. Raymond W. Lam has received honoraria for ad hoc speaking or advising/consulting, or received research funds from Akili, Allergan, Asia-Pacific Economic Cooperation, BC Leading Edge Foundation, Brain Canada, Canadian Institutes of Health Research, Canadian Network for Mood and Anxiety Treatments, Canadian Psychiatric Association, CME Institute, Hansoh, Janssen, Lundbeck, Lundbeck Institute, Medscape, Mind Mental Health Technologies, Otsuka, Pfizer, St. Jude Medical, University Health Network Foundation and Vancouver General Hospital Foundation.
: The authors assert that all procedures contributing to this work comply with the ethical standards of the relevant national and institutional committees on human experimentation and with the Helsinki Declaration of 1964, as revised in 2008. All procedures were approved by individual institutional research ethics boards.
: All participants provided written informed consent and received compensation for participation.
: All participants signed informed consent regarding publishing their data.
: The datasets generated during and/or analysed during the current study are not publicly available, but may be available on reasonable request upon permission by the CAN-BIND Investigator’s Team and Ontario Brain Institute. Syntax used for data analysis in SPSS are available upon reasonable request.
: All authors contributed to the study conception and design. Material preparation, data collection and analysis were performed by TC, SJM, IJT, BNF, RVM, DJM, SR, SHK and RWL. The first draft of the manuscript was written by TC and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.